Topics:
ARS 2014|Breast Cancer|Colorectal Cancer|Leukemia & Lymphoma|Lung Cancer|Melanoma|ASCO 2014|Prostate Cancer|Browse All Topics

Oncology and Hematology News and Journal Articles

Order of Gene Mutations May Affect Cancer Outcomes

New data indicates that the order in which people acquired certain somatic mutations influenced several clinical features of myeloproliferative neoplasms.

Recent Content

Sentinel Lymph Node Biopsy Indicated in Thick Melanomas

Leah Lawrence
News | March 02, 2015 | Melanoma
By

A single-institution study found that patients with melanomas of 4 mm thickness who had a negative sentinel lymph node biopsy had significantly prolonged survival.

Neutrophil-to-Lymphocyte Ratio Linked to mRCC Outcomes

Leah Lawrence
News | March 02, 2015 | ASCO 2015 Genitourinary Cancers Symposium, Genitourinary Cancers, Kidney Cancer, Renal Cell Carcinoma
By

Metastatic renal cell carcinoma patients with an elevated neutrophil-to-lymphocyte ratio at baseline had inferior outcomes compared those with a low ratio.

Adjuvant Chemotherapy Improves Survival in Bladder Cancer

Leah Lawrence
News | March 02, 2015 | ASCO 2015 Genitourinary Cancers Symposium, Bladder Cancer, Genitourinary Cancers
By

Patients with bladder cancer derived an overall survival benefit from the use of adjuvant chemotherapy compared with observation.

Two Clinical Factors May Predict PSA Response to Cabazitaxel

Anna Azvolinsky, PhD
News | March 02, 2015 | ASCO 2015 Genitourinary Cancers Symposium, Genitourinary Cancers, Prostate Cancer
By

Two clinical factors may predict PSA response to cabazitaxel in men with metastatic castration-resistant prostate cancer.

Study Confirms 4Kscore Accurately Predicts High-Grade Prostate Cancer

Anna Azvolinsky, PhD
News | March 02, 2015 | ASCO 2015 Genitourinary Cancers Symposium, Genitourinary Cancers, Prostate Cancer
By

The 4Kscore blood test has been shown to accurately detect the presence of high-grade prostate cancer, according to a study presented at ASCO GU.

High Cost, Minimal Benefit for Bevacizumab in Metastatic CRC

Leah Lawrence
News | March 02, 2015 | Colorectal Cancer, Gastrointestinal Cancer
By

Bevacizumab as first-line therapy for metastatic CRC equated to an incremental cost-effectiveness ratio of more than half a million dollars per QALY.

Physician Age May Affect Beliefs About Breast Cancer Screening

Leah Lawrence
News | March 01, 2015 | MBCC 2015, Breast Cancer
By

A physician’s age may have an effect on his or her opinions about the effectiveness of breast cancer screening methods, including self-exam and mammography.

View More Videos
View More Slideshows

By clicking Accept, you agree to become a member of the UBM Medica Community.